Skip to search formSkip to main contentSkip to account menu

maxacalcitol

Known as: 22-oxacalcitriol, 1,25-dihydroxy-22-oxavitamin D3, maxacalcitriol 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

Anticarcinogenic AgentsAntineoplastic AgentsCalcitriolDermatologic Agents

Narrower (1)

Oxarol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.
Fibroblast growth factor 23 (FGF23) is a regulator of phosphate and vitamin D homeostasis that carries out primary bone- and… 
2012
2012
22-oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model
2009
2009
Drug-induced acute pancreatitis associated with 22-oxacalcitriol ointment for treatment of psoriasis.
Hypercalcemia is usually caused by malignancies or primary hyperparathyroidism, and only rarely by drugs [1]. Hypercalcemia can… 
2006
2006
Effect of Maxacalcitol on Psoriasis Vulgaris-A Comparative Study of Maxacalcitol Ointment and High-concentration Tacalcitol Ointment-
尋常性乾癬患者18例を対象として，マキサカルシトール25μg/g軟膏(オキサロール®軟膏)とタカルシトール20μg/g軟膏(ボンアルファ®ハイ軟膏)の有効性を検討するため，左右比較試験を実施した。マキサカルシトール25μg/g軟膏は平日1日1回・土日1日2… 
2005
2005
A Comparative Study of Maxacalcitol Monotherapy, Clobetasol Propionate Monotherapy and the Combination of Each Agent as a Premixed Ointment for the Treatment of Psoriasis
尋常性乾癬に対するマキサカルシトール25μg/g軟膏(オキサロール®軟膏)とプロピオン酸クロベタゾール0.5mg/g軟膏(デルモベート®軟膏)それぞれの単独使用と両薬剤を混合したものの治療効果を比較検討した。対象患者64例をI～III群に分けて，I… 
2003
2003
Combination of 22-oxa-1,25-dihydroxyvitamin D3, a vitamin D3 derivative, with vitamin K2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells
2003
2003
Prospective comparison of the effects of maxacalcitol and of intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients
活性型ビタミンD静注製剤である, マキサカルシトールとカルシトリオールの透析患者の二次性副甲状腺機能亢進症に対する効果を比較検討した. また, 新たに開発された1-84副甲状腺ホルモン (PTH) のみを測定するwhole PTHの測定を行い, whole… 
1999
1999
Clinical efficacy of 22-oxacalcitriol against secondary hyperparathyroidism in hemodialysis patients
22-oxacalcitriol (OCT) は活性型ビタミンD3 (Vit D3) の誘導体であり, calcitriolと比べ血清Ca上昇作用が弱いことが報告されている. 今回我々は二次性副甲状腺機能亢進症 (2°HPT) を合併しVit D3… 
1997
1997
Characteristics of 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)-calcitriol (ED-71).
1993
1993
Tibial growth plate diameters in X-linked hypophosphatemic mice Effects of 22-oxacalcitriol and 1,25-dihydroxyvitamin D-3